APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Sevoflurane Anaesthetic Agent

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Inhalation Sevoflurane Anaesthetic Agent Industry Growth and Trends Forecast to 2032

2 January 202690 pages

Choose your research edition.

Industry ResearchInhalation Sevoflurane Anaesthetic Agent Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Sevoflurane Anaesthetic Agent Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Inhalation Sevoflurane Anaesthetic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Sevoflurane Anaesthetic Agent Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Sevoflurane Anaesthetic Agent Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Inhalation Sevoflurane Anaesthetic Agent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Inhalation Sevoflurane Anaesthetic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Inhalation Sevoflurane Anaesthetic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation Sevoflurane Anaesthetic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhalation Sevoflurane Anaesthetic Agent include Maruishi, Piramal, PT Novell Pharmaceutical, Viatris, AbbVie and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Inhalation Sevoflurane Anaesthetic Agent market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Inhalation Sevoflurane Anaesthetic Agent market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inhalation Sevoflurane Anaesthetic Agent market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inhalation Sevoflurane Anaesthetic Agent.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Inhalation Sevoflurane Anaesthetic Agent market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Inhalation Sevoflurane Anaesthetic Agent Market by Company

Maruishi

Piramal

PT Novell Pharmaceutical

Viatris

AbbVie

Baxter

Inhalation Sevoflurane Anaesthetic Agent Segment by Type

250ml/Bottle

120ml/Bottle

Other

Inhalation Sevoflurane Anaesthetic Agent Segment by Application

Hospital

Clinics

Other

Inhalation Sevoflurane Anaesthetic Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Sevoflurane Anaesthetic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Sevoflurane Anaesthetic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Sevoflurane Anaesthetic Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhalation Sevoflurane Anaesthetic Agent manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Inhalation Sevoflurane Anaesthetic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 250ml/Bottle Table 2. Major Company of 120ml/Bottle Table 3. Major Company of Other Table 4. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Type (2021-2026) Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (US$ Million) Table 8. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Type (2021-2026) Table 9. Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2021-2026) & (US$/Unit) Table 10. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2027-2032) & (K Units) Table 11. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Type (2027-2032) Table 12. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2027-2032) & (US$ Million) Table 13. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Type (2027-2032) Table 14. Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2027-2032) & (US$/Unit) Table 15. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 16. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 18. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 22. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (US$ Million) Table 25. Inhalation Sevoflurane Anaesthetic Agent Industry Trends Table 26. Inhalation Sevoflurane Anaesthetic Agent Industry Drivers Table 27. Inhalation Sevoflurane Anaesthetic Agent Industry Opportunities and Challenges Table 28. Inhalation Sevoflurane Anaesthetic Agent Industry Restraints Table 29. Global Inhalation Sevoflurane Anaesthetic Agent Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Company (2021-2026) Table 31. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Company (2021-2026) & (K Units) Table 32. Global Inhalation Sevoflurane Anaesthetic Agent Sales Share by Company (2021-2026) Table 33. Global Inhalation Sevoflurane Anaesthetic Agent Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Inhalation Sevoflurane Anaesthetic Agent Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Inhalation Sevoflurane Anaesthetic Agent Major Company Production Sites and Headquarters Table 36. Global Inhalation Sevoflurane Anaesthetic Agent Company, Product Type & Application Table 37. Global Inhalation Sevoflurane Anaesthetic Agent Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Inhalation Sevoflurane Anaesthetic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2021-2026) & (K Units) Table 42. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Region (2021-2026) Table 43. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2021-2026) & (US$ Million) Table 44. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Region (2021-2026) Table 45. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2027-2032) & (K Units) Table 47. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Region (2027-2032) Table 48. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2027-2032) & (US$ Million) Table 49. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Region (2027-2032) Table 50. Global Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 53. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Application (2021-2026) Table 54. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (US$ Million) Table 55. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Application (2021-2026) Table 56. Global Inhalation Sevoflurane Anaesthetic Agent Price by Application (2021-2026) & (US$/Unit) Table 57. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2027-2032) & (K Units) Table 58. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Application (2027-2032) Table 59. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2027-2032) & (US$ Million) Table 60. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Application (2027-2032) Table 61. Global Inhalation Sevoflurane Anaesthetic Agent Price by Application (2027-2032) & (US$/Unit) Table 62. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 63. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 65. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 69. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (US$ Million) Table 72. Maruishi Company Information Table 73. Maruishi Business Overview Table 74. Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 76. Maruishi Recent Development Table 77. Piramal Company Information Table 78. Piramal Business Overview Table 79. Piramal Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Piramal Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 81. Piramal Recent Development Table 82. PT Novell Pharmaceutical Company Information Table 83. PT Novell Pharmaceutical Business Overview Table 84. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 86. PT Novell Pharmaceutical Recent Development Table 87. Viatris Company Information Table 88. Viatris Business Overview Table 89. Viatris Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Viatris Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 91. Viatris Recent Development Table 92. AbbVie Company Information Table 93. AbbVie Business Overview Table 94. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 96. AbbVie Recent Development Table 97. Baxter Company Information Table 98. Baxter Business Overview Table 99. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 101. Baxter Recent Development Table 102. North America Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 104. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2021-2026) Table 105. North America Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2027-2032) & (K Units) Table 106. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Country (2027-2032) Table 107. North America Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Inhalation Sevoflurane Anaesthetic Agent Market Share by Country (2021-2026) Table 110. North America Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Inhalation Sevoflurane Anaesthetic Agent Market Share Forecast by Country (2027-2032) Table 112. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 114. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2021-2026) Table 115. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2027-2032) & (K Units) Table 116. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Inhalation Sevoflurane Anaesthetic Agent Market Share by Country (2021-2026) Table 120. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Inhalation Sevoflurane Anaesthetic Agent Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 124. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2027-2032) & (K Units) Table 126. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Share by Country (2021-2026) Table 130. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Share Forecast by Country (2027-2032) Table 132. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 134. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2021-2026) Table 135. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2027-2032) & (K Units) Table 136. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Share by Country (2021-2026) Table 140. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2027-2032) & (K Units) Table 146. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Share by Country (2021-2026) Table 150. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Inhalation Sevoflurane Anaesthetic Agent Distributors List Table 155. Inhalation Sevoflurane Anaesthetic Agent Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Inhalation Sevoflurane Anaesthetic Agent Image Figure 2. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhalation Sevoflurane Anaesthetic Agent Sales (2021-2032) & (K Units) Figure 5. 250ml/Bottle Image Figure 6. Global 250ml/Bottle Sales YoY Growth (2021-2032) & (K Units) Figure 7. 120ml/Bottle Image Figure 8. Global 120ml/Bottle Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Type 2025 VS 2032 Figure 13. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Type in 2025 Figure 14. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Type in 2025 Figure 15. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Type in 2025 Figure 16. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Type in 2025 Figure 19. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Inhalation Sevoflurane Anaesthetic Agent Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application 2025 VS 2032 Figure 33. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Application in 2025 Figure 34. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Application in 2025 Figure 35. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Application in 2025 Figure 36. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Application in 2025 Figure 39. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share in Value by Application in 2025 Figure 43. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Inhalation Sevoflurane Anaesthetic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Inhalation Sevoflurane Anaesthetic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Inhalation Sevoflurane Anaesthetic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Inhalation Sevoflurane Anaesthetic Agent Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Inhalation Sevoflurane Anaesthetic Agent Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 250ml/Bottle
  • 120ml/Bottle
  • Other
Applications
  • Hospital
  • Clinics
  • Other
Companies covered
  • Maruishi
  • Piramal
  • PT Novell Pharmaceutical
  • Viatris
  • AbbVie
  • Baxter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Inhalation Sevoflurane Anaesthetic Agent Market by Type
  6. 1.3.1 250ml/Bottle
  7. 1.3.2 120ml/Bottle
  8. 1.3.3 Other
  9. 1.4 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Type
  10. 1.4.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Inhalation Sevoflurane Anaesthetic Agent Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Inhalation Sevoflurane Anaesthetic Agent Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Inhalation Sevoflurane Anaesthetic Agent Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Inhalation Sevoflurane Anaesthetic Agent Industry Trends
  2. 2.2 Inhalation Sevoflurane Anaesthetic Agent Industry Drivers
  3. 2.3 Inhalation Sevoflurane Anaesthetic Agent Industry Opportunities and Challenges
  4. 2.4 Inhalation Sevoflurane Anaesthetic Agent Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2026)
  2. 3.2 Global Top Players by Inhalation Sevoflurane Anaesthetic Agent Sales (2021-2026)
  3. 3.3 Global Top Players by Inhalation Sevoflurane Anaesthetic Agent Price (2021-2026)
  4. 3.4 Global Inhalation Sevoflurane Anaesthetic Agent Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhalation Sevoflurane Anaesthetic Agent Major Company Production Sites & Headquarters
  6. 3.6 Global Inhalation Sevoflurane Anaesthetic Agent Company, Product Type & Application
  7. 3.7 Global Inhalation Sevoflurane Anaesthetic Agent Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhalation Sevoflurane Anaesthetic Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhalation Sevoflurane Anaesthetic Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhalation Sevoflurane Anaesthetic Agent Tier 1, Tier 2, and Tier 3
4 Inhalation Sevoflurane Anaesthetic Agent Regional Status and Outlook
  1. 4.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Inhalation Sevoflurane Anaesthetic Agent Historic Market Size by Region
  3. 4.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Inhalation Sevoflurane Anaesthetic Agent Forecasted Market Size by Region
  7. 4.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Inhalation Sevoflurane Anaesthetic Agent by Application
  1. 5.1 Inhalation Sevoflurane Anaesthetic Agent Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
  6. 5.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Inhalation Sevoflurane Anaesthetic Agent Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Maruishi
  2. 6.1.1 Maruishi Company Information
  3. 6.1.2 Maruishi Business Overview
  4. 6.1.3 Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  6. 6.1.5 Maruishi Recent Developments
  7. 6.2 Piramal
  8. 6.2.1 Piramal Company Information
  9. 6.2.2 Piramal Business Overview
  10. 6.2.3 Piramal Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Piramal Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  12. 6.2.5 Piramal Recent Developments
  13. 6.3 PT Novell Pharmaceutical
  14. 6.3.1 PT Novell Pharmaceutical Company Information
  15. 6.3.2 PT Novell Pharmaceutical Business Overview
  16. 6.3.3 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  18. 6.3.5 PT Novell Pharmaceutical Recent Developments
  19. 6.4 Viatris
  20. 6.4.1 Viatris Company Information
  21. 6.4.2 Viatris Business Overview
  22. 6.4.3 Viatris Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Viatris Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  24. 6.4.5 Viatris Recent Developments
  25. 6.5 AbbVie
  26. 6.5.1 AbbVie Company Information
  27. 6.5.2 AbbVie Business Overview
  28. 6.5.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  30. 6.5.5 AbbVie Recent Developments
  31. 6.6 Baxter
  32. 6.6.1 Baxter Company Information
  33. 6.6.2 Baxter Business Overview
  34. 6.6.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  36. 6.6.5 Baxter Recent Developments
7 North America by Country
  1. 7.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country
  2. 7.1.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026)
  4. 7.1.3 North America Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2027-2032)
  5. 7.2 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
  6. 7.2.1 North America Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2021-2026)
  8. 7.2.3 North America Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country
  2. 8.1.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026)
  4. 8.1.3 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
  6. 8.2.1 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2021-2026)
  8. 8.2.3 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Country
  2. 9.1.1 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
  6. 9.2.1 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Inhalation Sevoflurane Anaesthetic Agent Sales by Country
  2. 10.1.1 South America Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026)
  4. 10.1.3 South America Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2027-2032)
  5. 10.2 South America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
  6. 10.2.1 South America Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2021-2026)
  8. 10.2.3 South America Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country
  2. 11.1.1 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
  6. 11.2.1 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Inhalation Sevoflurane Anaesthetic Agent Value Chain Analysis
  2. 12.1.1 Inhalation Sevoflurane Anaesthetic Agent Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Inhalation Sevoflurane Anaesthetic Agent Production Mode & Process
  7. 12.2 Inhalation Sevoflurane Anaesthetic Agent Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Inhalation Sevoflurane Anaesthetic Agent Distributors
  10. 12.2.3 Inhalation Sevoflurane Anaesthetic Agent Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst